Early Cognitive Interventions in Digital Format for Cancer Survivors
NCT07729969
Summary
The aim of this study is to evaluate the usability and effectiveness of two professionally supervised home-based cognitive training interventions as part of an early rehabilitation protocol for cancer-related cognitive impairment. Participants will be randomized to one of the two intervention arms (computerized cognitive intervention or virtual reality cognitive intervention) or to the control group. Participants of the intervention groups will be assessed before and after the 10 weeks intervention or at equivalent time points for the control group. Comparisons between experimental and control participants, and between the participants in the two intervention arms, will be carried out to see which intervention is most effective and accepted.
Eligibility
Inclusion Criteria: * Patients over 18 years of age diagnosed with cancer (stage I-III) * Subjective complaints of cognitive functioning related to the diagnosis of cancer and/or cancer treatments * Between 1-6 months after completion of chemotherapy treatment * To have Wi-Fi and a computer/tablet * To sign the informed consent form Exclusion Criteria: * Previous history of cancer diagnosis * Anticipated change in cancer treatment/general medical treatment during the intervention period * Previous diagnosis of cognitive impairment * Diagnosis of other neurological or psychiatric diseases * Diagnosis of severe untreated depression * History of episodes of vertigo, epilepsy or seizures * Currently undergoing or having undergone any other type of intervention aimed at improving cognitive functioning (e.g., CRCI workshops) * Severe visual or hearing difficulties that may affect the performance of the intervention exercises * Inability to speak, understand, read, and write Spanish correctly * Failure to sign the informed consent form
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07729969